DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), a leader in innovative technology for medication delivery, today announced U.S. Food and Drug Administration (FDA) 510(k) ...

Baxter’s efforts this summer to correct high-risk issues with its infusion pumps has gotten more complicated. Last month, the company and the FDA alerted the public to a problem with the large-volume ...

Baxter told customers that its Novum IQ syringe infusion pump may fail to deliver a complete infusion and shared “reinforced guidance” to mitigate the risk. After one or more downstream occlusion ...

The FDA is spotlighting a new medical device correction effort at Baxter over its large-volume Novum IQ infusion pump, following reports of 79 serious injuries and two deaths linked to potential under ...

To date, there have been no reports of serious injury associated with this issue. Baxter International has issued an Urgent Medical Device Correction for the Novum IQ syringe infusion pump due to the ...

Baxter has issued a correction for its Novum IQ Large Volume Pumps and Novum IQ Syringe Pumps. All Novum large volume and syringe pumps have a software anomaly that ...

After a drawn-out approval process, medical equipment company Baxter International received regulatory clearance for a new infusion pump machine that is expected to help the company capture more of ...

New addition to Baxter’s Evo IQ Infusion Platform complements on-market large volumetric pump, offering opportunity to further help personalize treatment Incorporates web-based Dose IQ Safety Software ...

Furthers Baxter’s continued innovation in medication delivery and management Integrates Baxter’s decades of leadership in infusion therapy with innovative digital health solutions to build on the ...

DEERFIELD, Ill.--(BUSINESS WIRE)--Baxter International Inc. (NYSE:BAX), an innovative leader in infusion therapies and technologies, today announced U.S. Food and Drug Administration (FDA) 510(k) ...